"Antivirals" in the treatment of adult T cell leukaemia- lymphoma (ATLL).
about
Toward a Biology-Driven Treatment Strategy for Peripheral T-cell LymphomaHBZ stimulates brain-derived neurotrophic factor/TrkB autocrine/paracrine signaling to promote survival of human T-cell leukemia virus type 1-Infected T cellsImpaired expression of DICER and some microRNAs in HBZ expressing cells from acute adult T-cell leukemia patients.Integration site and clonal expansion in human chronic retroviral infection and gene therapy.SIRT1 Suppresses Human T-Cell Leukemia Virus Type 1 Transcription.Highlights from the HTLV-1 symposium at the 2017 Australasian HIV and AIDS Conference held jointly with the 2017 Australasian Sexual Health Conference, November 2017, Canberra, Australia.
P2860
"Antivirals" in the treatment of adult T cell leukaemia- lymphoma (ATLL).
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
"Antivirals" in the treatment of adult T cell leukaemia- lymphoma (ATLL).
@en
type
label
"Antivirals" in the treatment of adult T cell leukaemia- lymphoma (ATLL).
@en
prefLabel
"Antivirals" in the treatment of adult T cell leukaemia- lymphoma (ATLL).
@en
P2860
P1476
"Antivirals" in the treatment of adult T cell leukaemia- lymphoma (ATLL).
@en
P2093
Graham P Taylor
Paul A Fields
P2860
P2888
P304
P356
10.1007/S11899-012-0139-9
P577
2012-12-01T00:00:00Z
P6179
1028766543